Logo.gif
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
April 30, 2019 07:00 ET | iRadimed Corporation
Reports first quarter 2019 revenue of $8.4 millionReports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 (GLOBE NEWSWIRE) --...
Logo.gif
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th
April 16, 2019 07:00 ET | iRadimed Corporation
WINTER SPRINGS, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market...
Logo.gif
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
April 02, 2019 07:00 ET | iRadimed Corporation
WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”)...
Logo.gif
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
February 06, 2019 07:00 ET | iRadimed Corporation
Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first quarter financial...
Logo.gif
IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th
January 22, 2019 07:10 ET | iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market...
Logo.gif
IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue After Temporarily Suspending Shipments of MRI Compatible Patient Vital Signs Monitoring Systems in European Markets
January 22, 2019 07:00 ET | iRadimed Corporation
Action being taken after CE mark expirationExpects negative impact to full-year 2019 revenue of approximately two percent WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- IRADIMED...
Logo.gif
IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor
December 19, 2018 07:00 ET | iRadimed Corporation
WINTER SPRINGS, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today...
Logo.gif
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
October 30, 2018 07:00 ET | iRadimed Corporation
Reports third quarter 2018 revenue of $7.6 millionReports third quarter 2018 GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted...
Logo.gif
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
October 16, 2018 07:00 ET | iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market...
Logo.gif
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
September 11, 2018 07:00 ET | iRadimed Corporation
WINTER SPRINGS, Fla., Sept. 11, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today...